Introduction Early identification of tissue hypoperfusion is a cornerstone of shock management [1]. Normal macrohemodynamic and oxygen-derived parameters do not, however, rule out the presence of tissue hypoxia [2]. In this setting, carbon dioxide (CO2)-derived variables may provide information on macroand microvascular blood flow [3] and also on the presence of anaerobic metabolism [4, 5]. Importantly, variations in CO2 occur more rapidly than changes in lactate kinetics, making the former an attractive biomarker for monitoring, especially during the early stages of resuscitation [6, 7]
Tissue hypoxia is a common end product of circulatory shock and a primary target for resuscitation e...
The central venous blood is inadequate to assess the arterial oxygenation as the venous oxygen parti...
Tissue hypoxia is the central pathophysiological process in shock and an important co-factor in the ...
Introduction Early identification of tissue hypoperfusion is a cornerstone of shock management [1]. ...
BACKGROUND Venous-arterial carbon dioxide (CO2) to arterial-venous oxygen (O2) content difference...
Venous-to-arterial carbon dioxide difference (Pv-aCO2) may reflect the adequacy of blood flow during...
The central venous-arterial carbon dioxide tension gradient ('CO₂gap') has been shown to correlate w...
Venous-to-arterial carbon dioxide difference (Pv-aCO2) may reflect the adequacy of blood flow during...
Central venous-to-arterial carbon dioxide difference (PcvaCO2) has demonstrated its prognostic value...
Central venous-to-arterial carbon dioxide difference (PcvaCO2), and its correction by the arterial-t...
AbstractObjectiveRecently, the central venoarterial carbon dioxide difference/arterial-central venou...
Background and Aims: Tissue hypoperfusion is reflected by metabolic parameters such as lactate, cent...
Abstract Background Despite much evidence supporting the monitoring of the divergence of transcutane...
Purpose Septic shock has been associated with microvascular alterations and these in turn with th...
Background and aims: Venous to arterial difference of carbon dioxide (Pv–aCO2) tracks tissue blood f...
Tissue hypoxia is a common end product of circulatory shock and a primary target for resuscitation e...
The central venous blood is inadequate to assess the arterial oxygenation as the venous oxygen parti...
Tissue hypoxia is the central pathophysiological process in shock and an important co-factor in the ...
Introduction Early identification of tissue hypoperfusion is a cornerstone of shock management [1]. ...
BACKGROUND Venous-arterial carbon dioxide (CO2) to arterial-venous oxygen (O2) content difference...
Venous-to-arterial carbon dioxide difference (Pv-aCO2) may reflect the adequacy of blood flow during...
The central venous-arterial carbon dioxide tension gradient ('CO₂gap') has been shown to correlate w...
Venous-to-arterial carbon dioxide difference (Pv-aCO2) may reflect the adequacy of blood flow during...
Central venous-to-arterial carbon dioxide difference (PcvaCO2) has demonstrated its prognostic value...
Central venous-to-arterial carbon dioxide difference (PcvaCO2), and its correction by the arterial-t...
AbstractObjectiveRecently, the central venoarterial carbon dioxide difference/arterial-central venou...
Background and Aims: Tissue hypoperfusion is reflected by metabolic parameters such as lactate, cent...
Abstract Background Despite much evidence supporting the monitoring of the divergence of transcutane...
Purpose Septic shock has been associated with microvascular alterations and these in turn with th...
Background and aims: Venous to arterial difference of carbon dioxide (Pv–aCO2) tracks tissue blood f...
Tissue hypoxia is a common end product of circulatory shock and a primary target for resuscitation e...
The central venous blood is inadequate to assess the arterial oxygenation as the venous oxygen parti...
Tissue hypoxia is the central pathophysiological process in shock and an important co-factor in the ...